Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial

Roche’s Actemra may help fight pandemic after all with phase 3 trial results showing it cut the chances of COVID-19 patients, mainly from higher risk minority ethnic backgrounds with pneumonia, progressing to mechanical ventilation or death.